Related Experiment Video
Updated: Feb 21, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation
A M Masudul Azad Chowdhury1, Hiroki Katoh1, Atsushi Hatanaka1
1Laboratory for Genetic Code, Graduate School of Life and Medical Sciences, Doshisha University, Kyotanabe, Kyoto, Japan.
Abstract:
Accumulated evidence suggests a physiological relationship between the transcription factor NRF3 (NFE2L3) and cancers. Under physiological conditions, NRF3 is repressed by its endoplasmic reticulum (ER) sequestration. In response to unidentified signals, NRF3 enters the nucleus and modulates gene expression. However, molecular mechanisms underlying the nuclear translocation of NRF3 and its target gene in cancer cells remain poorly understood. We herein report that multiple regulation of NRF3 activities controls cell proliferation. Our analyses reveal that under physiological conditions, NRF3 is rapidly degraded by the ER-associated degradation (ERAD) ubiquitin ligase HRD1 and valosin-containing protein (VCP) in the cytoplasm. Furthermore, NRF3 is also degraded by β-TRCP, an adaptor for the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase in the nucleus. The nuclear translocation of NRF3 from the ER requires the aspartic protease DNA-damage inducible 1 homolog 2 (DDI2) but does not require inhibition of its HRD1-VCP-mediated degradation. Finally, NRF3 mediates gene expression of the cell cycle regulator U2AF homology motif kinase 1 (UHMK1) for cell proliferation. Collectively, our study provides us many insights into the molecular regulation and biological function of NRF3 in cancer cells.
Insights
Nuclear translocation of the transcription factor NRF3 (NFE2L3) is crucial for cancer cell proliferation. This study reveals NRF3
Area of Science:
- Molecular biology
- Cancer research
- Cellular signaling
Background:
- The transcription factor NRF3 (NFE2L3) plays a role in cancer, but its nuclear translocation and target genes are poorly understood.
- Under physiological conditions, NRF3 is sequestered in the endoplasmic reticulum (ER) and subject to degradation.
Purpose of the Study:
- To elucidate the molecular mechanisms regulating NRF3 nuclear translocation and its role in cancer cell proliferation.
- To identify the target genes modulated by NRF3 in cancer cells.
Main Methods:
- Investigated NRF3 degradation pathways in cytoplasm and nucleus using ubiquitin ligases HRD1, VCP, and β-TRCP.
- Utilized the aspartic protease DDI2 to study NRF3 nuclear translocation from the ER.
- Analyzed NRF3-mediated gene expression of UHMK1 in relation to cell proliferation.
Main Results:
- NRF3 is degraded in the cytoplasm by HRD1/VCP and in the nucleus by β-TRCP.
- Nuclear translocation of NRF3 from the ER is dependent on DDI2, independent of HRD1/VCP degradation.
- NRF3 regulates U2AF homology motif kinase 1 (UHMK1) gene expression, promoting cell proliferation.
Conclusions:
- NRF3 activity is multiply regulated, impacting cancer cell proliferation.
- DDI2 is essential for NRF3 nuclear translocation, while degradation pathways involve HRD1, VCP, and β-TRCP.
- NRF3's regulation of UHMK1 is a key mechanism driving cancer cell proliferation.
Related Concept Videos
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators

